FINWIRES · TerminalLIVE
FINWIRES

$HIMS

19 stories mentioning HIMS

Every FINWIRES story that references HIMS, newest first.

Sectors

Sector Update: Healthcare Stocks Down Premarket Tuesday

Healthcare stocks were lower premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.1% and the iShares Biotechnology ETF (IBB) easing 0.3%.Hims & Hers Health (HIMS) stock was up more than 2% after the company said it has completed its acquisition of Eucalyptus, expanding its consumer health platform across Australia, Canada, Germany, and other international markets.Heron Therapeutics (HRTX) shares were down 18% after the company said the US District Court for the District of Delaware has ruled that claims in two of its Cinvanti injectable emulsion patents are invalid.Telix Pharmaceuticals (TLX) and United Imaging Healthcare North America signed a memorandum of understanding for a research collaboration in the US focused on integrated theranostics solutions. Telix Pharmaceuticals stock was down more than 2% pre-bell.

$HIMS$HRTX$IBB$TLX$XLV
Commodities

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday as Traders Assess AI Momentum

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.2% and the actively traded Invesco QQQ Trust (QQQ) retreated by 0.1% in Tuesday's premarket activity, as investors assessed whether recent AI-driven gains can be sustained.US stock futures were also lower, with S&P 500 Index futures down 0.2%, Dow Jones Industrial Average futures slipping 0.5%, and Nasdaq futures losing 0.1% before the start of regular trading.The Job Openings and Labor Turnover Survey, or JOLTS, for April will be released at 10:00 am ET.In premarket action, bitcoin was down by 2.9%. Among cryptocurrency ETFs, the cryptocurrency fund ProShares Bitcoin Strategy ETF (BITO) was 2.9% lower, Ether ETF (EETH) retreated by 1.2%, and Bitcoin & Ether Market Cap Weight ETF (BETH) fell by 3%.Power Play:IndustrialThe State Street Industrial Select Sector SPDR ETF (XLI) was flat, while the Vanguard Industrials Index Fund (VIS) was down 0.1% and the iShares US Industrials ETF (IYJ) was inactive.Generac (GNRC) stock was up more than 9% before the opening bell after the company signed a global supply agreement with an unnamed hyperscale data center operator to supply backup power generators.Winners and Losers:FinancialThe State Street Financial Select Sector SPDR ETF (XLF) was little changed. Direxion Daily Financial Bull 3X Shares (FAS) was down 0.4%, while its bearish counterpart, Direxion Daily Financial Bear 3X Shares (FAZ), was 0.7% higher.UP Fintech (TIGR) shares were down more than 2% pre-bell after the company swung to a Q1 non-GAAP net loss.EnergyThe iShares US Energy ETF (IYE) was down 2%, while the State Street Energy Select Sector SPDR ETF (XLE) was 0.3% lower.BW LPG (BWLP) stock was up 0.7% before market open after the company reported higher Q1 earnings.HealthcareThe State Street Health Care Select Sector SPDR ETF (XLV), Vanguard Health Care Index Fund (VHT) and iShares US Healthcare ETF (IYH) were little changed. The iShares Biotechnology ETF (IBB) was inactive.Hims & Hers Health (HIMS) stock was up 3% premarket after the company said it had completed its acquisition of Eucalyptus, expanding its consumer health platform across Australia, Canada, Germany, and other international markets.TechnologyThe State Street Technology Select Sector SPDR ETF (XLK) gained slightly, and the iShares US Technology ETF (IYW) was marginally down, while the iShares Expanded Tech Sector ETF (IGM) was up 0.4%. Among semiconductor ETFs, the State Street SPDR S&P Semiconductor ETF (XSD) increased 3%, while the iShares Semiconductor ETF (SOXX) rose by 2.5%.Nvidia (NVDA) shares were up more than 1% in premarket activity after Reuters reported, citing CEO Jensen Huang at the Computex event in Taipei, that the company has enough supply to support strong growth in its central processing units and graphics processing units.ConsumerThe State Street Consumer Staples Select Sector SPDR ETF (XLP) was up 0.2%, and the Vanguard Consumer Staples Index Fund ETF Shares (VDC) was 0.4% lower. The iShares US Consumer Staples ETF (IYK) was flat. The State Street Consumer Discretionary Select Sector SPDR ETF (XLY) lost 0.5%. The VanEck Retail ETF (RTH) was inactive, while the State Street SPDR S&P Retail ETF (XRT) was 0.5% higher.Amazon.com (AMZN) shares were down more than 1% pre-bell, extending a 3.5% fall at Monday's close. The company said Tuesday its Prime Day shopping event will take place from June 23 through June 26.CommoditiesFront-month US West Texas Intermediate crude oil retreated by 0.8% to $91.41 per barrel on the New York Mercantile Exchange. Natural gas was down 1.8% to $3.12 per 1 million British Thermal Units. The United States Oil Fund (USO) was down by 1.1%, and the United States Natural Gas Fund (UNG) was 2% lower.Gold futures for July retreated by 1.2% to $4,558.30 an ounce on the Comex. Silver futures rose by 2% to $76.73 an ounce. SPDR Gold Shares (GLD) was up by 1%, and the iShares Silver Trust (SLV) increased by 1.9%.

Dow JonesNasdaq CompositeS&P 500$AMZN$BETH$BITO$BWLP$EEM$EETH$EXI$FAS$FAZ$GLD$GNRC$HIMS$IBB$IGM$IGV$IPK$IVV$IWM$IYE$IYH$IYJ$IYK$IYW$NVDA$PMR$QQQ$RTH$SLV$SOXX$SPY$TIGR$UNG$USO$VDC$VHT$VIS$XLE$XLF$XLI$XLK$XLP$XLV$XLY$XRT$XSD
Sectors

Sector Update: Healthcare

Healthcare stocks were steady premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) slightly advancing and the iShares Biotechnology ETF (IBB) inactive.Hims & Hers Health (HIMS) stock was up more than 3% after the company said it has completed its acquisition of Eucalyptus, expanding its consumer health platform across Australia, Canada, Germany, and other international markets.

$HIMS
Sectors

Sector Update: Healthcare Stocks Advance Late Afternoon

Healthcare stocks rose late Thursday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF (XLV) each adding about 0.7%.The iShares Biotechnology ETF (IBB) was up 0.8%.In corporate news, West Pharmaceutical Services (WST) shares rose 3.1% after the company said it has restored its core enterprise systems following a recent cybersecurity attack.Eli Lilly (LLY) shares added 2.6% after the company said its investigational retatrutide delivered "clinically meaningful" weight loss in a phase 3 trial, where all doses met the primary and key secondary endpoints at 80 weeks.Hims & Hers Health (HIMS) said Thursday that it has launched generic semaglutide for eligible customers in Canada. Its shares gained 2.7%.Moderna's (MRNA) experimental flu shot made with mRNA technology will be reviewed by a Food and Drug Administration advisory panel on June 18, Bloomberg reported. Moderna shares were down 1.5%.

$HIMS$LLY$MRNA$WST
Sectors

Sector Update: Healthcare Stocks Rise Thursday Afternoon

Healthcare stocks rose Thursday afternoon, with the NYSE Healthcare Index increasing 0.3% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 0.5%.The iShares Biotechnology ETF (IBB) was up 0.6%.In corporate news, Eli Lilly (LLY) shares rose 2.1% after the company said its investigational retatrutide delivered "clinically meaningful" weight loss in a phase 3 trial, where all doses met the primary and key secondary endpoints at 80 weeks.Hims & Hers Health (HIMS) said Thursday that it has launched generic semaglutide for eligible customers in Canada. Its shares popped 3.3%.Moderna's (MRNA) experimental flu shot made with mRNA technology will be reviewed by a Food and Drug Administration advisory panel on June 18, Bloomberg reported. Moderna shares were down 1.5%.

$HIMS$LLY$MRNA
Wire

Hims & Hers Launches Generic Semaglutide in Canada

Hims & Hers Health (HIMS) said Thursday that it has launched generic semaglutide for eligible customers in Canada.Canadian customers can access personalized treatment plans starting at 149 Canadian dollars ($108) per month, the company said.Care plans may include GLP-1 options alongside ongoing support and guidance on nutrition, movement and sleep, the company said.Price: $22.80, Change: $-0.22, Percent Change: -0.96%

$HIMS
Asia Markets

US Equity Futures Lower Pre-Bell as Trump Says Middle East Ceasefire on 'Life Support'

US equity futures were lower pre-bell Tuesday as the standoff continued in the Middle East, with the ceasefire between the US and Iran on shakier ground after President Donald Trump said it was "on life support."Dow Jones Industrial Average futures were 0.1% lower, S&P 500 futures were down 0.4%, and Nasdaq futures were 0.8% lower.Trump told reporters in the White House that the month-old truce is "unbelievably weak." He had rejected Iran's response to the US peace proposal. Iran's most recent counteroffer had included a demand for war reparations, an end to sanctions, full sovereignty over the Strait of Hormuz, and the release of frozen Iranian assets.Traders monitored the latest round of earnings, with Sea (SE) and Venture Global (VG) posting higher Q1 earnings and revenue.Oil prices were higher, with front-month global benchmark North Sea Brent crude up 3.2% at $107.57 per barrel and US West Texas Intermediate crude 3.1% higher at $101.08 per barrel.The April consumer price index, released at 8:30 am ET, gained 0.6% as expected, compared with a 0.9% increase in the previous month, according to estimates compiled by Bloomberg.Federal Reserve Chicago President Austan Goolsbee is slated to speak Tuesday.In other world markets, Japan's Nikkei closed 0.5% higher, Hong Kong's Hang Seng ended 0.2% lower, and China's Shanghai Composite finished 0.3% lower. Meanwhile, the UK's FTSE 100 was down 0.4%, and Germany's DAX index was 1.1% lower in Europe's early afternoon session.In equities, Novo Nordisk (NVO) stock was up 2.5% after the company said a higher dose of its Wegovy drug helped people with obesity lose "significant amounts" of weight irrespective of how quickly their body responds to the treatment, based on a new sub-analysis from a clinical trial. Sea and Venture Global shares were up 11% and 9.4%, respectively, after the companies reported their Q1 financial results.On the losing side, Dell Technologies (DELL) shares were down 2.1% after UBS downgraded the stock to neutral from buy. Hims & Hers Health (HIMS) stock was down 15% after the company reported a swing to Q1 loss.

Dow JonesNasdaq CompositeS&P 500$DELL$HIMS$NVO$SE$VG
Stocks Down Pre-Bell as US Rejects Iran's Response to Peace Plan; Investors Await Key Inflation Data
US Markets

Stocks Down Pre-Bell as US Rejects Iran's Response to Peace Plan; Investors Await Key Inflation Data

The benchmark US stock measures were pointing lower before the opening bell Monday as the US rejected Iran's response to its proposal to end their war in the Middle East, while traders await key inflation data later in the week.The S&P 500 and the Nasdaq edged down 0.1% each in premarket activity, while the Dow Jones Industrial Average was slightly in the red. The indexes finished Friday trading in the green, with the S&P 500 and the Nasdaq logging new closing highs.Iran formally sent a response to the latest US peace proposal, outlining its own demands and leaving key gaps between the two sides, The Wall Street Journal reported Sunday. Tehran's response didn't resolve Washington's demand for commitments on its nuclear program and stockpile of highly enriched uranium, according to the report."I have just read the response from Iran's so-called 'representatives,'" President Donald Trump said in a social media post on Sunday. "I don't like it - totally unacceptable!"Iran has reportedly insisted on compensation for war damages, control over the crucial Strait of Hormuz, lifting all sanctions on it and the release of frozen assets.Israeli Prime Minister Benjamin Netanyahu reportedly said in a recent interview with CBS that the war with Iran is not over. "There is still enrichment sites that have to be dismantled, there's still proxies that Iran supports, there are ballistic missiles that they still want to produce ... there's work to be done," Netanyahu said.West Texas Intermediate crude oil increased 2.5% to $97.79 a barrel before the open, while Brent advanced 2.4% to $103.72.Treasury yields were trending upwards in premarket action, with the two-year rate rising 2.9 basis points to 3.92% and the 10-year rate gaining 2.6 basis points to 4.39%.The consumer price index for April is scheduled to be released on Tuesday, followed by data on wholesale prices for the same month on Wednesday. Last month's retail sales report is due on Thursday.Last week, government data showed that the US economy added more jobs than expected in April, while the unemployment rate remained unchanged.For the Federal Reserve, the hiring momentum further shifts the focus to inflation, keeping it on the sidelines for now, "and raising the possibility of future rate hikes," Stifel Chief Economist Lindsey Piegza said in a report e-mailed toon Friday.Consumer sentiment continued to fall in May as cost pressures tied to the Middle East conflict sent the measure tumbling to fresh lows, a survey by the University of Michigan showed Friday.Monday's thin economic calendar has the existing home sales report for April at 10 am ET.Constellation Energy (CEG), Circle Internet (CRCL), Fox (FOX, FOXA), Mosaic (MOS) and Monday.com (MNDY) are slated to report their latest financial results before the bell, among others.Shares of Micron Technology (MU) rose 2.6% pre-bell after closing Friday's trading session up 16%. Hims & Hers Health (HIMS) added 4.5% after the stock closed 10% higher in the previous session. Intel (INTC) climbed 5.5%.Gold declined 1.3% to $4,671 per troy ounce, while bitcoin slipped 0.5% to $81,015.

Dow JonesNasdaq CompositeS&P 500$CEG$CRCL$FOX$FOXA$HIMS$INTC$MNDY$MOS$MU
Research

JPMorgan Initiates Coverage on Hims & Hers Health With Overweight Rating, $35 Price Target

Hims & Hers Health (HIMS) has an average rating of overweight and mean price target of $26.74, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$HIMS
Insider Trading

Hims & Hers Health Insider Sold Shares Worth $588,615, According to a Recent SEC Filing

Oluyemi Okupe, Chief Financial Officer, on April 20, 2026, sold 19,645 shares in Hims & Hers Health (HIMS) for $588,615. Following the Form 4 filing with the SEC, Okupe has control over a total of 270,807 Class A common shares of the company, with 262,954 shares held directly and 7,853 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1773751/000190705626000016/xslF345X05/wk-form4_1776893044.xml

$HIMS
Insider Trading

Hims & Hers Health Insider Sold Shares Worth $283,890, According to a Recent SEC Filing

Soleil Boughton, Chief Legal Officer, on April 20, 2026, sold 9,463 shares in Hims & Hers Health (HIMS) for $283,890. Following the Form 4 filing with the SEC, Boughton has control over a total of 299,368 Class A common shares of the company, with 299,368 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1773751/000183781726000009/xslF345X05/wk-form4_1776893050.xml

$HIMS
Insider Trading

Hims & Hers Health Insider Sold Shares Worth $1,457,305, According to a Recent SEC Filing

Oluyemi Okupe, Chief Financial Officer, on April 16, 2026, sold 54,927 shares in Hims & Hers Health (HIMS) for $1,457,305. Following the Form 4 filing with the SEC, Okupe has control over a total of 277,899 Class A common shares of the company, with 270,046 shares held directly and 7,853 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1773751/000190705626000014/xslF345X05/wk-form4_1776717480.xml

$HIMS
Sectors

Sector Update: Health Care Stocks Decline Late Afternoon

Health care stocks were softer late Thursday afternoon, with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF (XLV) each decreasing 0.7%.The iShares Biotechnology ETF (IBB) dropped 1.3%.In corporate news, Abbott Laboratories (ABT) lowered its full-year earnings outlook on Thursday to reflect the acquisition of cancer diagnostics company Exact Sciences, while the healthcare firm reported Q1 results above market estimates. Its shares fell past 5%.Gilead Sciences (GILD) could beat Q1 consensus estimates, but weaker-than-expected persistence rates for Yeztugo point to a potential risk to long-term peak sales for the HIV pre-exposure prophylaxis drug, RBC Capital Markets said in a note. Gilead shares were down 0.8%.QuidelOrtho (QDEL) shares tumbled 28%. The company said late Wednesday it expects preliminary unaudited revenue of $615 million to $620 million for Q1. Analysts polled by FactSet expect $677.8 million.Hims & Hers Health (HIMS) shares jumped past 12% after a senior US health official signaled plans to ease restrictions on certain peptides.

$ABT$GILD$HIMS$QDEL
Sectors

Sector Update: Health Care Stocks Slide in Afternoon Trading

Health care stocks declined Thursday afternoon, with the NYSE Health Care Index decreasing 0.8% and the State Street Health Care Select Sector SPDR ETF (XLV) falling 1%.The iShares Biotechnology ETF (IBB) dropped 1.2%.In corporate news, Abbott Laboratories (ABT) lowered its full-year earnings outlook on Thursday to reflect the acquisition of cancer diagnostics company Exact Sciences, while the healthcare firm reported Q1 results above market estimates. Its shares fell past 6%.QuidelOrtho (QDEL) shares tumbled 31%. The company said late Wednesday it expects preliminary unaudited revenue of $615 million to $620 million for Q1. Analysts polled by FactSet expect $677.8 million.Hims & Hers Health (HIMS) shares rose past 7% after a senior US health official signaled plans to ease restrictions on certain peptides.Organon (OGN) is a potential acquisition target by India's Sun Pharmaceutical Industries, Germany's Grunenthal, and private equity firms, Bloomberg reported. Organon shares added 0.7%.

$ABT$HIMS$OGN$QDEL
Wire

BofA Securities Lifts Price Target on Hims & Hers Health to $25 From $21, Maintains Neutral Rating

Hims & Hers Health (HIMS) has an average rating of overweight and mean price target of $25.65, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $25.49, Change: $+1.09, Percent Change: +4.47%

$HIMS
Sectors

Sector Update: Health Care Stocks Mixed Premarket Thursday

Health care stocks were mixed premarket Thursday, with the State Street Health Care Select Sector SPDR ETF (XLV) slightly higher and the iShares Biotechnology ETF (IBB) down 0.1%.Abbott Laboratories (ABT) stock was down more than 3% after the company issued Q2 adjusted earnings per share guidance below analysts' expectations, and lowered its 2026 adjusted EPS outlook.Hims & Hers Health (HIMS) shares were up more than 7% after a senior US health official signaled plans to ease restrictions on certain peptides.Organon (OGN) is a potential acquisition target by India's Sun Pharmaceutical Industries, Germany's Grunenthal, and private equity firms, Bloomberg reported, citing unnamed people familiar with the matter. Organon shares were up more than 5% pre-bell.

$ABT$HIMS$IBB$OGN$XLV
Sectors

Sector Update: Health Care

Health care stocks were leaning lower premarket Thursday, with the State Street Health Care Select Sector SPDR ETF (XLV) and iShares Biotechnology ETF (IBB) down 0.1%.Hims & Hers Health (HIMS) shares were up more than 8% after a senior US health official signaled plans to ease restrictions on certain peptides.

$HIMS
Commodities

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Amid Incoming Economic Data Releases

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.1%, and the actively traded Invesco QQQ Trust (QQQ) was 0.2% higher in Thursday's premarket activity amid incoming economic data releases.US stock futures were also edging higher, with S&P 500 Index futures up 0.1%, Dow Jones Industrial Average futures advancing 0.1%, and Nasdaq futures gaining 0.2% before the start of regular trading.US initial jobless claims came in at 207,000, compared with expectations of 213,000 and a prior reading of 218,000.The New York Fed's regional services index for April was negative 14.0, versus expectations of negative 20.0 and a prior reading of negative 22.6.The Philadelphia Fed's regional manufacturing index for April rose to 26.7, above expectations of 10.0 and a prior reading of 18.1.The industrial production data for March will be released at 9:15 am ET, followed by the weekly natural gas data at 10:30 am ET.Fed Governor Stephen Miran is slated to speak on Thursday.In premarket activity, bitcoin was down by 1%. Among cryptocurrency ETFs, the cryptocurrency fund ProShares Bitcoin Strategy ETF (BITO) was 0.8% lower, Ether ETF (EETH) retreated by 2.1%, and Bitcoin & Ether Market Cap Weight ETF (BETH) was flat.Power Play:Health CareThe State Street Health Care Select Sector SPDR ETF (XLV) advanced 0.01%, the Vanguard Health Care Index Fund (VHT) was up 0.7%, while the iShares US Healthcare ETF (IYH) was inactive. The iShares Biotechnology ETF (IBB) slipped 0.1%.Hims & Hers Health (HIMS) stock was up more than 9% premarket after US Health and Human Services Secretary Robert Kennedy Jr. signaled plans to ease restrictions on certain peptides.Winners and Losers:ConsumerThe State Street Consumer Staples Select Sector SPDR ETF (XLP) was up 0.1%, and the Vanguard Consumer Staples Index Fund ETF Shares (VDC) was flat. The iShares US Consumer Staples ETF (IYK) was flat. The State Street Consumer Discretionary Select Sector SPDR ETF (XLY) gained 0.1%. The VanEck Retail ETF (RTH) and the State Street SPDR S&P Retail ETF (XRT) were inactive.Alibaba (BABA) shares were up more than 3% pre-bell after Bloomberg reported the retailer has launched a new AI model that creates 3D environments and interactive videos, expanding into gaming and content to compete more directly with Tencent.TechnologyThe State Street Technology Select Sector SPDR ETF (XLK) advanced 0.4%, and the iShares US Technology ETF (IYW) was 0.1% higher, while the iShares Expanded Tech Sector ETF (IGM) was up 1.2%. Among semiconductor ETFs, the State Street SPDR S&P Semiconductor ETF (XSD) gained 0.6%, while the iShares Semiconductor ETF (SOXX) declined by 0.5%.Taiwan Semiconductor Manufacturing (TSM) shares were down more than 1% in Thursday's premarket activity even after the company reported higher Q1 earnings and net revenue.EnergyThe iShares US Energy ETF (IYE) was down 0.02% while the State Street Energy Select Sector SPDR ETF (XLE) was up by 0.02%.TotalEnergies (TTE) stock was up more than 1% before Thursday's opening bell after the company said that Q1 exploration and production results are expected to rise significantly, supported by higher oil prices and contributions from new projects.FinancialThe State Street Financial Select Sector SPDR ETF (XLF) advanced 0.02%. Direxion Daily Financial Bull 3X Shares (FAS) was up 0.1%, while its bearish counterpart, Direxion Daily Financial Bear 3X Shares (FAZ), was 0.02% higher.Travelers (TRV) shares were down more than 1% pre-bell after the company's Q1 revenue trailed the estimates of analysts polled by FactSet.IndustrialThe State Street Industrial Select Sector SPDR ETF (XLI) advanced 0.3%, while the Vanguard Industrials Index Fund (VIS) retreated 0.3% and the iShares US Industrials ETF (IYJ) was inactive.Willdan Group (WLDN) stock was up more than 1% before the opening bell after the company was awarded a $27 million, three-year contract with the New York City Mayor's Office of Climate & Environmental Justice to redesign and implement the NYC Accelerator program.CommoditiesFront-month US West Texas Intermediate crude oil gained by 0.2% to reach $91.45 per barrel on the New York Mercantile Exchange. Natural gas retreated by 0.2% to $2.61 per 1 million British Thermal Units. The United States Oil Fund (USO) increased by 0.8%, while the United States Natural Gas Fund (UNG) was 0.5% higher.Gold futures for May were up by 0.3% at $4,840.00 an ounce on the Comex. Silver futures gained by 0.1% to reach $79.68 an ounce. SPDR Gold Shares (GLD) was 0.4% higher, and the iShares Silver Trust (SLV) advanced by 0.3%.

Dow JonesNasdaq CompositeS&P 500$BABA$BETH$BITO$EEM$EETH$EXI$FAS$FAZ$GLD$HIMS$IBB$IGM$IGV$IPK$IVV$IWM$IYE$IYH$IYJ$IYK$IYW$PMR$QQQ$RTH$SLV$SOXX$SPY$TRV$TSM$TTE$UNG$USO$VDC$VHT$VIS$WLDN$XLE$XLF$XLI$XLK$XLP$XLV$XLY$XRT$XSD
Wire

Hims & Hers Health Shares Rise Pre-Bell as US FDA Moves to Ease Peptide Restrictions

Hims & Hers Health (HIMS) shares rose over 7% pre-bell Thursday after a senior US health official signaled plans to ease restrictions on certain peptides.The US Food and Drug Administration will remove 12 peptides from its category 2 list, with the substances set for review by an advisory committee in July, US Health and Human Services Secretary Robert Kennedy Jr. said in a post on X.The changes could expand regulated access to peptide-based treatments and shift demand away from black markets, Kennedy said.Price: $26.16, Change: $+1.87, Percent Change: +7.70%

$HIMS
HIMS News | FINWIRES